A circadian clock in hippocampus is regulated by interaction between oligophrenin-1 and Rev-erbα

Nat Neurosci. 2011 Aug 28;14(10):1293-301. doi: 10.1038/nn.2911.

Abstract

Oligophrenin-1 regulates dendritic spine morphology in the brain. Mutations in the oligophrenin-1 gene (OPHN1) cause intellectual disability. We discovered a previously unknown partner of oligophrenin-1, Rev-erbα, a nuclear receptor that represses the transcription of circadian oscillators. We found that oligophrenin-1 interacts with Rev-erbα in the mouse brain, causing it to locate to dendrites, reducing its repressor activity and protecting it from degradation. Our results indicate the presence of a circadian oscillator in the hippocampus, involving the clock gene Bmal1 (also known as Arntl), that is modulated by Rev-erbα and requires oligophrenin-1 for normal oscillation. We also found that synaptic activity induced Rev-erbα localization to dendrites and spines, a process that is mediated by AMPA receptor activation and requires oligophrenin-1. Our data reveal new interactions between synaptic activity and circadian oscillators, and delineate a new means of communication between nucleus and synapse that may provide insight into normal plasticity and the etiology of intellectual disability.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • ARNTL Transcription Factors / genetics
  • ARNTL Transcription Factors / metabolism
  • Analysis of Variance
  • Animals
  • Bicuculline / pharmacology
  • Cells, Cultured
  • Cerebral Cortex / cytology
  • Chlorocebus aethiops
  • Circadian Clocks / genetics
  • Circadian Clocks / physiology*
  • Cysteine Proteinase Inhibitors / pharmacology
  • Cytoskeletal Proteins / deficiency
  • Cytoskeletal Proteins / genetics
  • Cytoskeletal Proteins / metabolism*
  • Dendrites / metabolism
  • Drug Interactions
  • Embryo, Mammalian
  • Excitatory Amino Acid Antagonists / pharmacology
  • GABA-A Receptor Antagonists / pharmacology
  • GTPase-Activating Proteins / deficiency
  • GTPase-Activating Proteins / genetics
  • GTPase-Activating Proteins / metabolism*
  • Gene Expression Regulation / genetics
  • Green Fluorescent Proteins / genetics
  • Hippocampus / cytology*
  • Humans
  • Immunoprecipitation
  • Leupeptins / pharmacology
  • Mice
  • Mice, Knockout
  • Mutation / genetics
  • Neurons / cytology
  • Neurons / drug effects
  • Neurons / physiology*
  • Nuclear Proteins / deficiency
  • Nuclear Proteins / genetics
  • Nuclear Proteins / metabolism*
  • Nuclear Receptor Subfamily 1, Group D, Member 1 / genetics
  • Nuclear Receptor Subfamily 1, Group D, Member 1 / metabolism*
  • Quinoxalines / pharmacology
  • RNA, Messenger / metabolism
  • RNA, Small Interfering / pharmacology
  • Rats
  • Sodium Channel Blockers / pharmacology
  • Tetrodotoxin / pharmacology
  • Time Factors
  • Transfection / methods
  • Two-Hybrid System Techniques
  • Valine / analogs & derivatives
  • Valine / pharmacology

Substances

  • ARNTL Transcription Factors
  • Cysteine Proteinase Inhibitors
  • Cytoskeletal Proteins
  • Excitatory Amino Acid Antagonists
  • GABA-A Receptor Antagonists
  • GTPase-Activating Proteins
  • Leupeptins
  • NR1D1 protein, human
  • Nuclear Proteins
  • Nuclear Receptor Subfamily 1, Group D, Member 1
  • OPHN1 protein, human
  • Quinoxalines
  • RNA, Messenger
  • RNA, Small Interfering
  • Sodium Channel Blockers
  • 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline
  • Green Fluorescent Proteins
  • Tetrodotoxin
  • 2-amino-5-phosphopentanoic acid
  • Valine
  • benzyloxycarbonylleucyl-leucyl-leucine aldehyde
  • Bicuculline